Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The growing threat of antibiotic-resistant bacteria necessitates the continuous development of novel antimicrobial agents. Ozenoxacin, a quinolone antibiotic with CAS number 245765-41-7, represents a significant advancement in this area. Its unique properties make it particularly effective against strains that have developed resistance to existing treatments. Understanding the comparative advantages, such as in Ozenoxacin vs fluoroquinolones, is key to appreciating its role.
Ozenoxacin distinguishes itself through its potent activity against a wide range of Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE). These highly resistant strains pose a major challenge in clinical settings, and Ozenoxacin offers a powerful tool to combat them. Its efficacy stems from its precise targeting of bacterial DNA gyrase A and topoisomerase IV, enzymes crucial for bacterial survival.
Researchers seeking to explore these advanced antibacterial properties often look to buy Ozenoxacin for research. The ability of Ozenoxacin to bypass common resistance mechanisms that affect traditional fluoroquinolones makes it an attractive candidate for developing new therapeutic strategies. This makes Ozenoxacin a vital component in the ongoing fight against antimicrobial resistance.
The effectiveness of Ozenoxacin as a topical antibiotic for impetigo highlights its clinical utility. Impetigo is a common skin infection that can be caused by Staphylococcus aureus or Streptococcus pyogenes. Ozenoxacin's ability to penetrate the skin and target these pathogens directly contributes to its success in treating such conditions. As a NINGBO INNO PHARMCHEM CO.,LTD. partner, we ensure the availability of high-quality Ozenoxacin to facilitate these critical applications.
Delving into the Ozenoxacin antibiotic mechanism reveals its specific action as a Ozenoxacin DNA gyrase inhibitor. This focused approach allows it to exert strong bactericidal effects without being susceptible to certain resistance pathways. This makes Ozenoxacin a valuable asset for companies like NINGBO INNO PHARMCHEM CO.,LTD. that are committed to advancing antibacterial therapies and meeting the global demand for effective treatments.
In summary, Ozenoxacin offers a compelling solution for tackling antibiotic-resistant bacteria. Its distinct mechanism, broad spectrum of activity, and successful clinical applications position it as a leading agent in modern antimicrobial therapy. NINGBO INNO PHARMCHEM CO.,LTD. is proud to supply Ozenoxacin, supporting the vital research and development efforts needed to combat resistant infections.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
